Previous close | 36.90 |
Open | N/A |
Bid | 35.70 |
Ask | 39.70 |
Strike | 80.00 |
Expiry date | 2025-01-17 |
Day's range | 36.90 - 36.90 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Glaukos announces positive second Phase 3 confirmatory pivotal trial for Epioxa.
ARAY's solid product demand and revenue growth raise optimism about the stock.
DEERFIELD, Ill., October 16, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2024 financial results on Friday, November 8, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/attendee/391655054 to pre-register for the call and receive the call information.